Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Overview of attention for article published in BMC Cancer, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 4 X users
patent: 2 patents

facebook: 1 Facebook page

Readers on

mendeley: 45 Mendeley

Summary X Patents Facebook

So far, Altmetric has seen 2 patents that reference this research output.

REAGENTS AND METHODS FOR CANCER DETECTION, PROGNOSIS, AND THERAPEUTIC MONITORING

Application WO-2020251916-A3

World Intellectual Property Organisation (WIPO)

REAGENTS AND METHODS FOR MONITORING BREAST CANCER THERAPY

Application EP-3502701-A3

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.